Sample Answer for NURS 6521 Case Study 1 HH is a 68 yo M who Has Been Admitted to the Medical Ward Included After Question<\/strong><\/em><\/span><\/h2>\nDiscussion: Women\u2019s and Men\u2019s Health, Infectious Disease, and Hematologic Disorders<\/a><\/span><\/b>\u00a0<\/span><\/p>\nAs an advanced practice nurse, you will likely experience patient encounters with complex comorbidities. For example, consider a female patient who is pregnant who also presents with hypertension, diabetes, and has a recent tuberculosis infection. How might the underlying pathophysiology of these conditions affect the pharmacotherapeutics you might recommend to help address your patient\u2019s health needs? What education strategies might you recommend for ensuring positive patient health outcomes?<\/span>\u00a0<\/span><\/p>\nFor this Discussion, you will be assigned a patient case study and will consider how to address the patient\u2019s current drug therapy plans. You will then suggest recommendations on how to revise these drug therapy plans to ensure effective, safe, and quality patient care for positive patient health outcomes.<\/span>\u00a0<\/span><\/p>\n![\"NURS](\"http:\/\/nursingassignmentcrackers.com\/wp-content\/uploads\/2024\/02\/Capture-7-4-300x74.png\")
NURS 6521 Case Study 1 HH is a 68 yo M who Has Been Admitted to the Medical Ward<\/figcaption><\/figure>\nPhoto Credit: Getty Images<\/span>\u00a0<\/span><\/p>\nTo Prepare<\/span><\/b>\u00a0<\/span><\/h2>\n\n- Review the Resources for this module and reflect on the different health needs and body systems presented.<\/span>\u00a0<\/span><\/li>\n
- Your Instructor will assign you a complex case study to focus on for this Discussion.<\/span>\u00a0<\/span><\/li>\n
- Consider how you will practice critical decision making for prescribing appropriate drugs and treatment to address the complex patient health needs in the patient case study you selected.<\/span>\u00a0<\/span><\/li>\n<\/ul>\n
By Day 3 of Week 9<\/span><\/b>\u00a0<\/span><\/h2>\nPost<\/span><\/b> a brief description of your patient\u2019s health needs from the patient case study you assigned. Be specific. Then, explain the type of treatment regimen you would recommend for treating your patient, including the choice or pharmacotherapeutics you would recommend and explain why. Be sure to justify your response. Explain a patient education strategy you might recommend for assisting your patient with the management of their health needs. Be specific and provide examples.<\/span>\u00a0<\/span><\/p>\nYou will respond to your colleagues\u2019 posts in Week 10.<\/span>\u00a0<\/span><\/p>\nNote:<\/span><\/i><\/b> For this Discussion, you are required to complete your initial post before you will be able to view and respond to your colleagues\u2019 postings. Begin by clicking on the \u201cPost to Discussion Question\u201d link, and then select \u201cCreate Thread\u201d to complete your initial post. Remember, once you click on Submit, you cannot delete or edit your own posts, and you cannot post anonymously. Please check your post carefully before clicking on <\/span><\/i>Submit!<\/span><\/i><\/b>\u00a0<\/span><\/p>\nA Sample Answer For the Assignment: NURS 6521 Case Study 1 HH is a 68 yo M who Has Been Admitted to the Medical Ward<\/strong><\/h2>\nTitle: NURS 6521 Case Study 1 HH is a 68 yo M who Has Been Admitted to the Medical Ward<\/strong><\/h2>\nAn undergrad physiology professor of mine once said “Many people say men and women are the same, but there is a Vas Deferens between us”<\/span><\/p>\nStudents with last names beginning with A-M please do case study 1: HH is a 68 yo M who has been admitted to the medical ward with community-acquired\u202fpneumonia for the past 3 days. His PMH is significant for COPD, HTN, hyperlipidemia,\u202fand diabetes. He remains on empiric antibiotics, which include ceftriaxone 1 g IV qday\u202f(day 3) and azithromycin 500 mg IV qday (day 3). Since admission, his clinical status\u202fhas improved, with decreased oxygen requirements. He is not tolerating a diet at this\u202ftime with complaints of nausea and vomiting. Ht: 5\u20198\u201d Wt: 89 kg, Allergies: Penicillin (rash)<\/p>\n
Week 9. Mr. HH’s Case Study\u00a0<\/span>\u00a0<\/span><\/h2>\n\u202fHH is a 68-year-old M who has been admitted to the medical ward with community-acquired\u202fPneumonia for the past three days. His PMH is significant for COPD, HTN, hyperlipidemia,\u202fand diabetes. He remains on empiric antibiotics, including ceftriaxone 1 g IV qday\u202f(day 3), and Azithromycin 500 mg IV q day (day 3). Since admission, his clinical status\u202fhas improved, with decreased oxygen requirements. He is not tolerating a diet at this\u202ftime, with complaints of nausea and vomiting. Ht: 5\u20198\u201d Wt: 89 kg, Allergies: Penicillin (rash)<\/span>\u00a0<\/span><\/p>\n\u202f<\/span>\u00a0<\/span><\/p>\n\u202f\u202f\u202f\u202f\u202f\u202fAccording to the presented case study, Mr. HH, a 68-year-old male, has been diagnosed with community-acquired Pneumonia. The Centers for Disease Control and Prevention (CDC) (2020) defines Pneumonia as a lung infection that can cause mild to severe ailments to people of all ages. \u202fPrina, Ranzani & Torres (2015) states that the clinical presentation of community-acquired Pneumonia is the acute symptoms and immediate signs of lower respiratory infection. The most exhibited symptoms being new-onset chest pain, cough, dyspnea, fever, etc. (Prina, Ranzani & Torres, 2015). <\/span>\u00a0<\/span><\/p>\nPatient\u2019s health needs <\/span>\u00a0<\/span><\/h2>\nPatient HH needs a complete assessment\/triage to fully obtain a timeline on when his symptoms and other occurrences led to hospitalization. Need a complete set of vital signs and bedside finger stick to proceed with a plan of care. Pt needs O2 saturation monitoring, needs IV hydration, and nutrition.\u00a0<\/span>\u00a0<\/span><\/p>\n\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f HH\u2019s cause of nausea and vomiting is unknown as it is not a symptom of community-acquired Pneumonia (CAP) (Prina, Ranzani & Torres, 2015). Resolution of nausea and vomiting will improve the patient\u2019s dietary status and prevent possible hypoglycemia, as the patient has diabetes. HH presented with other medical problems like COPD, Hypertension, Hyperlipidemia, and Diabetes and has been on antibiotics for three days since hospital admission.\u00a0<\/span>\u00a0<\/span><\/p>\nTreatment Regime<\/span>\u00a0<\/span><\/h2>\nIt is essential to mention that this patient was placed on a broad-spectrum antibiotic regime, Azithromycin, a treatment plan utilized when the causative agent, either bacteria or fungus, is unknown (Rosenthal & Burchum 2021). HH needs blood work and respiratory cultures to determine the agent causing his current infection so that the specific antibiotic can be initiated, bearing in mind that he is allergic to Penicillin. The patient is also on Ceftriaxone for three days as part of his treatment plan. Rosenthal & Burchum (2021) states that Ceftriaxone is utilized to treat all various types of common bacterial infection and critical ones like Meningitis, E. coli, and Pneumonia. Therefore, the IV antibiotics need to be continued for five to seven days and patient re-evaluated for their effectiveness before discontinuation to avoid developing patient resistance to a specific antibiotic (Metlay et al., 2019).\u00a0<\/span>\u00a0<\/span><\/p>\nDue to not tolerating diet well, patient HH needs IV hydration and nutrition therapy until nausea and vomiting is resolved to avoid dehydration and electrolyte imbalance from an unknown period of said symptoms.\u00a0<\/span>\u00a0<\/span><\/p>\nI would recommend placing the patient on D51\/2 NS to maintain adequate hydration, provide nutrients, balance electrolytes, and maintain blood sugar level and frequent Accu- checks.\u00a0<\/span>\u00a0<\/span><\/p>\n\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f It is also worthy to note that the patient\u2019s respiratory treatment is improving and respiratory medications utilized were not listed. The first-line medication for COPD exacerbation \/ respiratory treatment and management are Anti-inflammatory and B2 agonists. Rosenthal & Burchum (2021) opined that these medications work by minimizing bronchial hyperreactivity, thereby eliminating respiratory inflammation and decreasing the production of mucus in the respiratory tract. \u202f<\/span>\u00a0<\/span><\/p>\nPatient Education<\/span>\u00a0<\/span><\/h2>\n\u202f<\/span>\u00a0<\/span>The patient should be educated on the need to monitor his oxygen level closely and weaned off accordingly if he is not oxygen dependent at home. The patient will be educated on the importance of living a more active lifestyle, using an Incentive spirometer for lung expansion, to inhibit mucus plug and pneumonia reinfection. The patient will be educated on the need to closely monitor his blood pressure to maintain his baseline. Patient dietary plan and medication compliance need to be reviewed with the patient to manage hyperlipidemia adequately. It is crucial for education and follow-up to be continually provided to the patient to understand that HTN, HLD, and DM place him at an alarming risk for stroke. \u202f<\/span>\u00a0<\/span><\/p>\n\u202f<\/span>References\u00a0<\/span>\u00a0<\/span><\/h2>\nCenters for Disease Control and Prevention (2020). Pneumonia an infection of the lungs. <\/span>Cdc.gov <\/span><\/i>Retrieved from <\/span>https:\/\/www.cdc.gov\/pneumonia\/index.html<\/span><\/a> \u202f<\/span>\u00a0<\/span><\/p>\nMetlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Crothers, K., Cooley, L. A., Dean, C. N., Fine, M. J., Flanders, S. A., Griffin, M. R., Metersky, M. L., Musher, D. M., Restrepo, M. I. & Whitney, C. G. (2019). Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Disease Society of America. <\/span>Infectious Disease Society of America<\/span><\/i> Retrieved from <\/span>https:\/\/www.idsociety.org\/practice-guideline\/community-acquired-pneumonia-cap-in-adults\/<\/span><\/a>\u00a0<\/span><\/p>\n
As an advanced practice nurse, you will likely experience patient encounters with complex comorbidities. For example, consider a female patient who is pregnant who also presents with hypertension, diabetes, and has a recent tuberculosis infection. How might the underlying pathophysiology of these conditions affect the pharmacotherapeutics you might recommend to help address your patient\u2019s health needs? What education strategies might you recommend for ensuring positive patient health outcomes?<\/span>\u00a0<\/span><\/p>\n For this Discussion, you will be assigned a patient case study and will consider how to address the patient\u2019s current drug therapy plans. You will then suggest recommendations on how to revise these drug therapy plans to ensure effective, safe, and quality patient care for positive patient health outcomes.<\/span>\u00a0<\/span><\/p>\n Photo Credit: Getty Images<\/span>\u00a0<\/span><\/p>\n Post<\/span><\/b> a brief description of your patient\u2019s health needs from the patient case study you assigned. Be specific. Then, explain the type of treatment regimen you would recommend for treating your patient, including the choice or pharmacotherapeutics you would recommend and explain why. Be sure to justify your response. Explain a patient education strategy you might recommend for assisting your patient with the management of their health needs. Be specific and provide examples.<\/span>\u00a0<\/span><\/p>\n You will respond to your colleagues\u2019 posts in Week 10.<\/span>\u00a0<\/span><\/p>\n Note:<\/span><\/i><\/b> For this Discussion, you are required to complete your initial post before you will be able to view and respond to your colleagues\u2019 postings. Begin by clicking on the \u201cPost to Discussion Question\u201d link, and then select \u201cCreate Thread\u201d to complete your initial post. Remember, once you click on Submit, you cannot delete or edit your own posts, and you cannot post anonymously. Please check your post carefully before clicking on <\/span><\/i>Submit!<\/span><\/i><\/b>\u00a0<\/span><\/p>\n An undergrad physiology professor of mine once said “Many people say men and women are the same, but there is a Vas Deferens between us”<\/span><\/p>\n Students with last names beginning with A-M please do case study 1: HH is a 68 yo M who has been admitted to the medical ward with community-acquired\u202fpneumonia for the past 3 days. His PMH is significant for COPD, HTN, hyperlipidemia,\u202fand diabetes. He remains on empiric antibiotics, which include ceftriaxone 1 g IV qday\u202f(day 3) and azithromycin 500 mg IV qday (day 3). Since admission, his clinical status\u202fhas improved, with decreased oxygen requirements. He is not tolerating a diet at this\u202ftime with complaints of nausea and vomiting. Ht: 5\u20198\u201d Wt: 89 kg, Allergies: Penicillin (rash)<\/p>\n \u202fHH is a 68-year-old M who has been admitted to the medical ward with community-acquired\u202fPneumonia for the past three days. His PMH is significant for COPD, HTN, hyperlipidemia,\u202fand diabetes. He remains on empiric antibiotics, including ceftriaxone 1 g IV qday\u202f(day 3), and Azithromycin 500 mg IV q day (day 3). Since admission, his clinical status\u202fhas improved, with decreased oxygen requirements. He is not tolerating a diet at this\u202ftime, with complaints of nausea and vomiting. Ht: 5\u20198\u201d Wt: 89 kg, Allergies: Penicillin (rash)<\/span>\u00a0<\/span><\/p>\n \u202f<\/span>\u00a0<\/span><\/p>\n \u202f\u202f\u202f\u202f\u202f\u202fAccording to the presented case study, Mr. HH, a 68-year-old male, has been diagnosed with community-acquired Pneumonia. The Centers for Disease Control and Prevention (CDC) (2020) defines Pneumonia as a lung infection that can cause mild to severe ailments to people of all ages. \u202fPrina, Ranzani & Torres (2015) states that the clinical presentation of community-acquired Pneumonia is the acute symptoms and immediate signs of lower respiratory infection. The most exhibited symptoms being new-onset chest pain, cough, dyspnea, fever, etc. (Prina, Ranzani & Torres, 2015). <\/span>\u00a0<\/span><\/p>\n Patient HH needs a complete assessment\/triage to fully obtain a timeline on when his symptoms and other occurrences led to hospitalization. Need a complete set of vital signs and bedside finger stick to proceed with a plan of care. Pt needs O2 saturation monitoring, needs IV hydration, and nutrition.\u00a0<\/span>\u00a0<\/span><\/p>\n \u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f HH\u2019s cause of nausea and vomiting is unknown as it is not a symptom of community-acquired Pneumonia (CAP) (Prina, Ranzani & Torres, 2015). Resolution of nausea and vomiting will improve the patient\u2019s dietary status and prevent possible hypoglycemia, as the patient has diabetes. HH presented with other medical problems like COPD, Hypertension, Hyperlipidemia, and Diabetes and has been on antibiotics for three days since hospital admission.\u00a0<\/span>\u00a0<\/span><\/p>\n It is essential to mention that this patient was placed on a broad-spectrum antibiotic regime, Azithromycin, a treatment plan utilized when the causative agent, either bacteria or fungus, is unknown (Rosenthal & Burchum 2021). HH needs blood work and respiratory cultures to determine the agent causing his current infection so that the specific antibiotic can be initiated, bearing in mind that he is allergic to Penicillin. The patient is also on Ceftriaxone for three days as part of his treatment plan. Rosenthal & Burchum (2021) states that Ceftriaxone is utilized to treat all various types of common bacterial infection and critical ones like Meningitis, E. coli, and Pneumonia. Therefore, the IV antibiotics need to be continued for five to seven days and patient re-evaluated for their effectiveness before discontinuation to avoid developing patient resistance to a specific antibiotic (Metlay et al., 2019).\u00a0<\/span>\u00a0<\/span><\/p>\n Due to not tolerating diet well, patient HH needs IV hydration and nutrition therapy until nausea and vomiting is resolved to avoid dehydration and electrolyte imbalance from an unknown period of said symptoms.\u00a0<\/span>\u00a0<\/span><\/p>\n I would recommend placing the patient on D51\/2 NS to maintain adequate hydration, provide nutrients, balance electrolytes, and maintain blood sugar level and frequent Accu- checks.\u00a0<\/span>\u00a0<\/span><\/p>\n \u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f It is also worthy to note that the patient\u2019s respiratory treatment is improving and respiratory medications utilized were not listed. The first-line medication for COPD exacerbation \/ respiratory treatment and management are Anti-inflammatory and B2 agonists. Rosenthal & Burchum (2021) opined that these medications work by minimizing bronchial hyperreactivity, thereby eliminating respiratory inflammation and decreasing the production of mucus in the respiratory tract. \u202f<\/span>\u00a0<\/span><\/p>\n \u202f<\/span>\u00a0<\/span>The patient should be educated on the need to monitor his oxygen level closely and weaned off accordingly if he is not oxygen dependent at home. The patient will be educated on the importance of living a more active lifestyle, using an Incentive spirometer for lung expansion, to inhibit mucus plug and pneumonia reinfection. The patient will be educated on the need to closely monitor his blood pressure to maintain his baseline. Patient dietary plan and medication compliance need to be reviewed with the patient to manage hyperlipidemia adequately. It is crucial for education and follow-up to be continually provided to the patient to understand that HTN, HLD, and DM place him at an alarming risk for stroke. \u202f<\/span>\u00a0<\/span><\/p>\n Centers for Disease Control and Prevention (2020). Pneumonia an infection of the lungs. <\/span>Cdc.gov <\/span><\/i>Retrieved from <\/span>https:\/\/www.cdc.gov\/pneumonia\/index.html<\/span><\/a> \u202f<\/span>\u00a0<\/span><\/p>\n Metlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Crothers, K., Cooley, L. A., Dean, C. N., Fine, M. J., Flanders, S. A., Griffin, M. R., Metersky, M. L., Musher, D. M., Restrepo, M. I. & Whitney, C. G. (2019). Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Disease Society of America. <\/span>Infectious Disease Society of America<\/span><\/i> Retrieved from <\/span>https:\/\/www.idsociety.org\/practice-guideline\/community-acquired-pneumonia-cap-in-adults\/<\/span><\/a>\u00a0<\/span><\/p>\nTo Prepare<\/span><\/b>\u00a0<\/span><\/h2>\n
\n
By Day 3 of Week 9<\/span><\/b>\u00a0<\/span><\/h2>\n
A Sample Answer For the Assignment: NURS 6521 Case Study 1 HH is a 68 yo M who Has Been Admitted to the Medical Ward<\/strong><\/h2>\n
Title: NURS 6521 Case Study 1 HH is a 68 yo M who Has Been Admitted to the Medical Ward<\/strong><\/h2>\n
Week 9. Mr. HH’s Case Study\u00a0<\/span>\u00a0<\/span><\/h2>\n
Patient\u2019s health needs <\/span>\u00a0<\/span><\/h2>\n
Treatment Regime<\/span>\u00a0<\/span><\/h2>\n
Patient Education<\/span>\u00a0<\/span><\/h2>\n
\u202f<\/span>References\u00a0<\/span>\u00a0<\/span><\/h2>\n